1. Home
  2. LSTA vs ANY Comparison

LSTA vs ANY Comparison

Compare LSTA & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • ANY
  • Stock Information
  • Founded
  • LSTA 1980
  • ANY N/A
  • Country
  • LSTA United States
  • ANY United States
  • Employees
  • LSTA N/A
  • ANY N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • ANY Finance: Consumer Services
  • Sector
  • LSTA Health Care
  • ANY Finance
  • Exchange
  • LSTA Nasdaq
  • ANY Nasdaq
  • Market Cap
  • LSTA 24.2M
  • ANY 25.5M
  • IPO Year
  • LSTA N/A
  • ANY N/A
  • Fundamental
  • Price
  • LSTA $2.58
  • ANY $1.06
  • Analyst Decision
  • LSTA Strong Buy
  • ANY Strong Buy
  • Analyst Count
  • LSTA 1
  • ANY 1
  • Target Price
  • LSTA $15.00
  • ANY $3.00
  • AVG Volume (30 Days)
  • LSTA 19.6K
  • ANY 957.0K
  • Earning Date
  • LSTA 11-12-2024
  • ANY 11-14-2024
  • Dividend Yield
  • LSTA N/A
  • ANY N/A
  • EPS Growth
  • LSTA N/A
  • ANY N/A
  • EPS
  • LSTA N/A
  • ANY N/A
  • Revenue
  • LSTA N/A
  • ANY $21,657,000.00
  • Revenue This Year
  • LSTA N/A
  • ANY N/A
  • Revenue Next Year
  • LSTA N/A
  • ANY $16.70
  • P/E Ratio
  • LSTA N/A
  • ANY N/A
  • Revenue Growth
  • LSTA N/A
  • ANY 38.44
  • 52 Week Low
  • LSTA $2.19
  • ANY $0.67
  • 52 Week High
  • LSTA $3.83
  • ANY $4.09
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 41.13
  • ANY 38.70
  • Support Level
  • LSTA $2.48
  • ANY $1.20
  • Resistance Level
  • LSTA $2.77
  • ANY $1.31
  • Average True Range (ATR)
  • LSTA 0.19
  • ANY 0.13
  • MACD
  • LSTA -0.01
  • ANY -0.04
  • Stochastic Oscillator
  • LSTA 56.52
  • ANY 3.02

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Digital Mining and Service and Product. The Digital Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

Share on Social Networks: